Experience the Freedom and Flexibility of Visian ICL
Life is all about the experiences, and we want you to enjoy every single one. Visian ICL is made for those that want to live life without the hassle of glasses or contacts.
What is Visian ICL?
Visian ICL, also called an Implantable Contact Lens, is a refractive implant to correct common vision issues like myopia (nearsightedness) and astigmatism. Unlike LASIK, the Visian ICL is an additive technology that corrects vision without the removal of any corneal tissue. The Visian ICL is meant to be a permanent vision correction solution, but it can also be removable, if necessary.
Visian ICL Procedure – What to Expect
Visian ICL is made of biocompatible Collamer material that works in harmony with your eye. Your eye doctor will create a small opening in your cornea that will be used to insert and position the Visian ICL. The procedure is typically painless with numbing eye drops and it typically takes less than 20 – 30 minutes. You can experience improved vision right away and a quick, virtually painless recovery.
Benefits of Visian ICL
- Significant vision improvement
- 99% patient satisfaction
- Over 1 million procedures performed worldwide
- Quick results
- Can be removed, if needed
- Offers UV protection
- Undetectable once in place
- Can treat astigmatism and myopia
- May be an option for patients who are not candidates for other vision correction procedures, like LASIK or PRK
- Does not cause dry eye syndrome, which can be a side effect of laser vision procedures
- Provides excellent night vision
Common Questions About Visian ICL
The Visian ICL™ (Implantable Contact Lens) is an advanced soft-material lens composed of 100% biocompatible collagen copolymer. It provides UV protection and permanent vision correction, while giving patients a quality of vision that is sharper and clearer than that what one can achieve with glasses or contacts. Visian ICL is an additive technology, unlike LASIK that permanently alters the shape of your cornea. There is no maintenance associated with the lens, and it is intended to remain in place as long as you are satisfied with your vision. If at any point your vision changes or you wish to have them removed, it can be done easily and without compromising your current vision whatsoever.
If you are between the ages of 21 and 45 and nearsighted, you may be an excellent candidate for the Visian ICL. This procedure is able to treat a range of patients from low to extremely high prescriptions and is especially beneficially to those with thin corneas and dry eyes. The Visian ICL can now treat nearsightedness and astigmatism at the same time. If you have both astigmatism and nearsightedness, Visian Toric ICL may be a great option. It is preferable that the patient has not undergone any ophthalmic surgery and does not have a history of eye disease such as iritis, glaucoma, or diabetic retinopathy.
Yes. The Visian ICL received approval from the FDA for a wide range of myopic (nearsightedness) correction needs, with and without astigmatism.
Extensive research and development preceded the introduction of the Visian ICL. It is now being enjoyed by more than 1,000,000 eyes worldwide. The satisfaction rate among patients is extremely high – above 99%. The Visian ICL provides unparalleled quality of vision and has excellent and stable outcomes for patients with nearsightedness. The Visian ICL has been available internationally for over 20 years.
Although the lens is intended to remain in place permanently, a surgeon can remove the implant if necessary.
The Visian ICL is designed to be completely unobtrusive after it is put in place. It stays in position by itself and does not interact with any of the eye’s anatomy.
Feel free to contact Boulder Eyes with any questions that you may have, or to schedule an eye exam to discover if the Visian ICL or another vision correction procedure is right for you.
 Shin, JY. Ahn, H. Seo, KY. Kim, EK. Kim, TK. Comparison of higher order aberrations after implantable collamer lens implantation and wavefront-guide LASEK in high myopia. J Refract Surg. 2012; 28(2): 106 -111
 MICL PMA data
 Data on file. STAAR Surgical.
 Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantation in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473 – 481
 Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.
 Parkhurst G. A Prospective Comparison of Phakic Collamer Lenses and Wavefront-Optimized Laser-Assisted in Situ Keratomileusis for Correction of Myopia. Clinical Ophthalmology 2013; 10: 1209-1215.